Study on the Efficacy and Safety of Transarterial Chemoembolization Combined With Targeted Immunotherapy in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT06715072 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06715072
- Sponsor
- Yao Xie
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.